[1] Dunham I, Kundaje A, Aldred S F, et al. An integrated encyclopedia of DNA elements in the human genome [J]. Nature, 2012, 489(7414): 57-74.
[2] Lee Y, Ahn C, Han J, et al. The nuclear RNase Ⅲ Drosha initiates microRNA processing [J]. Nature, 2003, 425(6956): 415-419.
[3] Lee Y, Jeon K, Lee J T, et al. MicroRNA maturation: stepwise processing and subcellular localization [J]. EMBO J, 2002, 21(17): 4663-4670.
[4] Khvorova A, Reynolds A, Jayasena S D. Functional siRNAs and miRNA exhibit strand bias [J]. Cell, 2003, 115(2): 209-216.
[5] Zhao Y, Ransom J F, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 [J]. Cell, 2007, 129(2): 303-317.
[6] Chen J F, Murchison E P, Tang R, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure [J]. Proc Natl Acad Sci USA, 2008, 105(6): 2111-2116.
[7] Rao P K, Toyama Y, Chiang H R, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure [J]. Circ Res, 2009, 105(6): 585-594.
[8] Ding J, Chen J, Wang Y, et al. Trbp regulates heart function through microRNA-mediated Sox6 repression [J]. Nature Genetics, 2015, DOI: 10.1038/ng.3324.
[9] Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific micro-RNA that targets Hand2 during cardiogenesis [J]. Nature, 2005, 436(7048): 214-220.
[10] Liu N, Bezprozvannaya S, Williams W, et al. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smoothmuscle gene expression in the heart [J]. Genes Dev, 2008, 22(23): 3242-3254.
[11] Van R E, Sutherland L B, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure [J]. Proc Natl Acad Sci USA, 2006, 103(48): 18255-18260.
[12] Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts [J]. Nature, 2008, 456(7224): 980-984.
[13] Patrick D M, Montgomery R L, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice [J]. J Clin Invest, 2010, 120(11): 3912-3916.
[14] Lin Z, Murtaza I, Wang K, et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy [J]. Proc Natl Acad Sci USA, 2009, 106(10): 12103-12108.
[15] Dong Z, Ma J, Yu Y, et al. Silencing of miR-195 reduces diabetic cardiomyopathy in mice [J]. Diabetologia, 2015, 58(8): 1949-1958.
[16] Huang Z P, Chen J, Seok H Y, et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress [J]. Circ Res, 2013, 112(5): 1234-1243.
[17] Hee Y S, Chen J, Masaharu K, et al. Loss of microRNA-155 protects the heart from pathological cardiac hypertrophy [J]. Circ Res, 2014, 114(10): 1585-1595.
[18] Van R E, Quiat D, Johnson B A, et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance [J]. Dev Cell, 2009, 17(5): 662-673.
[19] Callis T E, Pandya K, Seok H Y, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice [J]. J Clin Invest, 2009, 119(9): 2772-2786.
[20] Van R E, Sutherland L B, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA [J]. Science, 2007, 316(5824): 575-579.
[21] Duisters R F, Tijsen A J, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocarolial matrix remodeling [J]. Circ Res, 2009, 104(2): 170-178.
[22] Van R E, Sutherland L B, Thatcher J E, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis [J]. Proc Natl Acad Sci USA, 2008, 105: 13027-13032.
[23] Bergmann O, Bhardwaj R D, Bernard S, et al. Evidence for cardiomyocyte renewal in humans [J]. Science, 2009, 324: 98-102.
[24] Porrello E R, Mahmoud A I, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart [J]. Science, 2011, 331: 1078-1080.
[25] Porrello E R, Johnson B A, Aurora A B, et al. miR-15 family regulates postnatal mitotic arrest of cardiomyocytes [J]. Circ Res, 2011, 109(6): 670-679.
[26] Li G, Kristy M, Wang Z Q, et al. STAT5 requires the N-domain for suppression of miR-15/16, induction of Bcl-2, and survival signaling in myeloproliferative disease [J]. Blood, 2010, 115(7): 1416-1424.
[27] Cimmino A, Calin G A, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting Bcl-2 [J]. Proc Natl Acad Sci USA, 2005, 102(39): 13944-13949.
[28] Eulalio A, Mano M, Dal F M, et al. Functional screening identifies miRNA inducing cardiac regeneration [J]. Nature, 2012, 492: 376-381.
[29] Chen J, Huang Z P, Seok H Y, et al. miR-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts [J]. Circ Res, 2013, 112: 1557-1566.
[30] Tian Y, Liu Y, Wang T, et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice [J]. Science Translational Medicine, 2015, 7: 279-291.
[31] Qian L, Huang Y, Spencer C I, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes [J]. Nature, 2012, 485: 593-598.
[32] Song K, Nam Y J, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors [J]. Nature, 2012, 485: 599-604.
[33] Nam Y J, Song K, Luo X, et al. Reprogramming of human fibroblasts toward a cardiac fate [J]. Proc Natl Acad Sci USA, 2013, 110: 5588-5593.
[34] Tilanthi M J, Elizabeth A F, Lunan Z, et al. MicroRNA induced cardiac reprogramming in vivo [J]. Circ Res, 2016, DOI: 10.1161/circresaha.116.304510.
[35] Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large noncoding RNAs in mammals [J]. Nature, 2009, 458(7235): 223-227.
[36] Yadava R S, Frenzel C D, Yu Q, et al. RNA toxicity in myotonic muscular dystrophy induces Nkx2.5 expression [J]. Nat Genet, 2008, 40(1): 61-68.
[37] Freedrichs F, Zugak C, Rauch G J, et al. HBEGF, SRA1, and IK: three cosegregating genes as determinants of cardiomyopathy [J]. Genome Res, 2009, 19(3): 395-403.
[38] Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA [J]. Cell, 2011, 147(2): 358-369.
[39] Klattenhoff C A, Scheuermann J C, Surface L E, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment [J]. Cell, 2013, 152(3): 570-583.
[40] Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse [J]. Dev Cell, 2013, 24(2): 206-214.
[41] Han P, Li W, Lin C H, et al. A long noncoding RNA protects the heart from pathological hypertrophy [J]. Nature, 2014, 514(7520): 102-106.
[42] Regalla K, Christophe B, Ingo V, et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure [J]. Circ Res, 2014, 114(10): 1569-1575.
[43] Wang K, Liu F, Zhou L Y, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489 [J]. Circ Res, 2014, 114(9): 1377-1388.
[44] Zhou Q, Chuang A C, Huang X R, et al. Identification of novel long noncoding RNAs associated with TGF /smad3-mediated renal inflammation and fibrosis by RNA sequencing [J]. Am J Pathol, 2014, 184(2): 409-417. |